What if blocking a particular brain receptor could help combat treatment-resistant depression?

Dean Henri Ford sits down with Kirill Martemyanov, Ph.D., to learn about a previously unrecognized brain receptor that may hold the key to treating major depressive disorder, including the treatment-resistant cases that leave so many patients without relief.

The findings, recently published in Nature, point toward a bold new approach to treating these disorders, one that may lead to entirely new class of therapies called “nanobodies.”

The results are striking.

Tune in to hear Dr. Martemyanov share the science, the journey to the discovery, and what this could mean for the future of mental health treatment.